1. Home
  2. ITRM vs LGCL Comparison

ITRM vs LGCL Comparison

Compare ITRM & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • LGCL
  • Stock Information
  • Founded
  • ITRM 2015
  • LGCL 2009
  • Country
  • ITRM Ireland
  • LGCL China
  • Employees
  • ITRM N/A
  • LGCL N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • LGCL
  • Sector
  • ITRM Health Care
  • LGCL
  • Exchange
  • ITRM Nasdaq
  • LGCL NYSE
  • Market Cap
  • ITRM 36.3M
  • LGCL 39.7M
  • IPO Year
  • ITRM 2018
  • LGCL 2024
  • Fundamental
  • Price
  • ITRM $0.97
  • LGCL $0.63
  • Analyst Decision
  • ITRM Strong Buy
  • LGCL
  • Analyst Count
  • ITRM 2
  • LGCL 0
  • Target Price
  • ITRM $7.00
  • LGCL N/A
  • AVG Volume (30 Days)
  • ITRM 515.1K
  • LGCL 92.2K
  • Earning Date
  • ITRM 05-13-2025
  • LGCL 01-01-0001
  • Dividend Yield
  • ITRM N/A
  • LGCL N/A
  • EPS Growth
  • ITRM N/A
  • LGCL N/A
  • EPS
  • ITRM N/A
  • LGCL 0.07
  • Revenue
  • ITRM N/A
  • LGCL $145,690,427.00
  • Revenue This Year
  • ITRM N/A
  • LGCL N/A
  • Revenue Next Year
  • ITRM $108.39
  • LGCL N/A
  • P/E Ratio
  • ITRM N/A
  • LGCL $9.15
  • Revenue Growth
  • ITRM N/A
  • LGCL N/A
  • 52 Week Low
  • ITRM $0.81
  • LGCL $0.28
  • 52 Week High
  • ITRM $3.02
  • LGCL $3.31
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 45.57
  • LGCL N/A
  • Support Level
  • ITRM $0.93
  • LGCL N/A
  • Resistance Level
  • ITRM $1.05
  • LGCL N/A
  • Average True Range (ATR)
  • ITRM 0.05
  • LGCL 0.00
  • MACD
  • ITRM 0.01
  • LGCL 0.00
  • Stochastic Oscillator
  • ITRM 50.00
  • LGCL 0.00

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About LGCL LUCAS GC LIMITED

Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.

Share on Social Networks: